Competitive (AP7) and non-competitive (MK-801) NMDA receptor antagonists differentially alter glucose utilization in rat cortex

D. W. Clow, S. J. Lee, Ronald P Hammer

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The effects of D,L-2-amino-7-phosphonoheptanoic acid (AP7), a competitive N-methyl-D-aspartate (NMDA) receptor antagonist, and MK-801, a non-competitive NMDA receptor antagonist, on regional brain metabolism were studied in unanesthetized, freely moving rats by using the quantitative [14C]2-deoxyglucose autoradiographic procedure. AP7 (338 or 901 mg/kg) produced a dose-dependent decrease of metabolic activity throughout most of the regions studied including sensory, motor, and limbic cortices. In contrast, MK-801 (0.1 or 1.0 mg/kg) resulted in a dose-dependent decrease of metabolic activity in sensory cortices, and an increase in limbic regions such as the hippocampal stratum lacunosum moleculare and entorhinal cortex. MK-801 also produced a biphasic response in agranular motor cortex, whereby the low dose increased while the high dose decreased labeling. In addition, MK-801 produced heterogeneous effects on regional cerebral metabolism in sensory cortices. Metabolic activity decreased in layer IV relative to layer Va following MK-801 treatment in primary somatosensory (S(I)) and visual (V(I)) cortices, suggesting a shift in activity from afferent fibers innervating layer IV to those innervating layer Va. MK-801 administration also decreased metabolic activity in granular S(I) relative to dysgranular S(I), and in V(I) relative to secondary visual cortex (V(II)), thus providing a relative sparing of activity in dysgranular S(I) and V(II). Thus, the non-competitive NMDA receptor antagonist suppressed activity from extrinsic neocortical sources, enhancing relative intracortical activity and stimulating limbic regions, while the competitive NMDA antagonist depressed metabolic activity in all cortical regions. These selective laminar and regional changes in metabolic activity may be due to an enhanced susceptibility of certain cortical circuits to non-competitive NMDA receptor antagonists.

Original languageEnglish (US)
Pages (from-to)260-268
Number of pages9
JournalSynapse
Volume7
Issue number4
StatePublished - 1991
Externally publishedYes

Fingerprint

Dizocilpine Maleate
N-Methyl-D-Aspartate Receptors
Glucose
2-amino-7-phosphonoheptanoic acid
Entorhinal Cortex
Deoxyglucose
Motor Cortex
Visual Cortex
N-Methylaspartate
Brain

ASJC Scopus subject areas

  • Physiology
  • Neuroscience(all)
  • Pharmacology

Cite this

Competitive (AP7) and non-competitive (MK-801) NMDA receptor antagonists differentially alter glucose utilization in rat cortex. / Clow, D. W.; Lee, S. J.; Hammer, Ronald P.

In: Synapse, Vol. 7, No. 4, 1991, p. 260-268.

Research output: Contribution to journalArticle

@article{23fbb2fdd20441f2ba91d377fb44e8a1,
title = "Competitive (AP7) and non-competitive (MK-801) NMDA receptor antagonists differentially alter glucose utilization in rat cortex",
abstract = "The effects of D,L-2-amino-7-phosphonoheptanoic acid (AP7), a competitive N-methyl-D-aspartate (NMDA) receptor antagonist, and MK-801, a non-competitive NMDA receptor antagonist, on regional brain metabolism were studied in unanesthetized, freely moving rats by using the quantitative [14C]2-deoxyglucose autoradiographic procedure. AP7 (338 or 901 mg/kg) produced a dose-dependent decrease of metabolic activity throughout most of the regions studied including sensory, motor, and limbic cortices. In contrast, MK-801 (0.1 or 1.0 mg/kg) resulted in a dose-dependent decrease of metabolic activity in sensory cortices, and an increase in limbic regions such as the hippocampal stratum lacunosum moleculare and entorhinal cortex. MK-801 also produced a biphasic response in agranular motor cortex, whereby the low dose increased while the high dose decreased labeling. In addition, MK-801 produced heterogeneous effects on regional cerebral metabolism in sensory cortices. Metabolic activity decreased in layer IV relative to layer Va following MK-801 treatment in primary somatosensory (S(I)) and visual (V(I)) cortices, suggesting a shift in activity from afferent fibers innervating layer IV to those innervating layer Va. MK-801 administration also decreased metabolic activity in granular S(I) relative to dysgranular S(I), and in V(I) relative to secondary visual cortex (V(II)), thus providing a relative sparing of activity in dysgranular S(I) and V(II). Thus, the non-competitive NMDA receptor antagonist suppressed activity from extrinsic neocortical sources, enhancing relative intracortical activity and stimulating limbic regions, while the competitive NMDA antagonist depressed metabolic activity in all cortical regions. These selective laminar and regional changes in metabolic activity may be due to an enhanced susceptibility of certain cortical circuits to non-competitive NMDA receptor antagonists.",
author = "Clow, {D. W.} and Lee, {S. J.} and Hammer, {Ronald P}",
year = "1991",
language = "English (US)",
volume = "7",
pages = "260--268",
journal = "Synapse",
issn = "0887-4476",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Competitive (AP7) and non-competitive (MK-801) NMDA receptor antagonists differentially alter glucose utilization in rat cortex

AU - Clow, D. W.

AU - Lee, S. J.

AU - Hammer, Ronald P

PY - 1991

Y1 - 1991

N2 - The effects of D,L-2-amino-7-phosphonoheptanoic acid (AP7), a competitive N-methyl-D-aspartate (NMDA) receptor antagonist, and MK-801, a non-competitive NMDA receptor antagonist, on regional brain metabolism were studied in unanesthetized, freely moving rats by using the quantitative [14C]2-deoxyglucose autoradiographic procedure. AP7 (338 or 901 mg/kg) produced a dose-dependent decrease of metabolic activity throughout most of the regions studied including sensory, motor, and limbic cortices. In contrast, MK-801 (0.1 or 1.0 mg/kg) resulted in a dose-dependent decrease of metabolic activity in sensory cortices, and an increase in limbic regions such as the hippocampal stratum lacunosum moleculare and entorhinal cortex. MK-801 also produced a biphasic response in agranular motor cortex, whereby the low dose increased while the high dose decreased labeling. In addition, MK-801 produced heterogeneous effects on regional cerebral metabolism in sensory cortices. Metabolic activity decreased in layer IV relative to layer Va following MK-801 treatment in primary somatosensory (S(I)) and visual (V(I)) cortices, suggesting a shift in activity from afferent fibers innervating layer IV to those innervating layer Va. MK-801 administration also decreased metabolic activity in granular S(I) relative to dysgranular S(I), and in V(I) relative to secondary visual cortex (V(II)), thus providing a relative sparing of activity in dysgranular S(I) and V(II). Thus, the non-competitive NMDA receptor antagonist suppressed activity from extrinsic neocortical sources, enhancing relative intracortical activity and stimulating limbic regions, while the competitive NMDA antagonist depressed metabolic activity in all cortical regions. These selective laminar and regional changes in metabolic activity may be due to an enhanced susceptibility of certain cortical circuits to non-competitive NMDA receptor antagonists.

AB - The effects of D,L-2-amino-7-phosphonoheptanoic acid (AP7), a competitive N-methyl-D-aspartate (NMDA) receptor antagonist, and MK-801, a non-competitive NMDA receptor antagonist, on regional brain metabolism were studied in unanesthetized, freely moving rats by using the quantitative [14C]2-deoxyglucose autoradiographic procedure. AP7 (338 or 901 mg/kg) produced a dose-dependent decrease of metabolic activity throughout most of the regions studied including sensory, motor, and limbic cortices. In contrast, MK-801 (0.1 or 1.0 mg/kg) resulted in a dose-dependent decrease of metabolic activity in sensory cortices, and an increase in limbic regions such as the hippocampal stratum lacunosum moleculare and entorhinal cortex. MK-801 also produced a biphasic response in agranular motor cortex, whereby the low dose increased while the high dose decreased labeling. In addition, MK-801 produced heterogeneous effects on regional cerebral metabolism in sensory cortices. Metabolic activity decreased in layer IV relative to layer Va following MK-801 treatment in primary somatosensory (S(I)) and visual (V(I)) cortices, suggesting a shift in activity from afferent fibers innervating layer IV to those innervating layer Va. MK-801 administration also decreased metabolic activity in granular S(I) relative to dysgranular S(I), and in V(I) relative to secondary visual cortex (V(II)), thus providing a relative sparing of activity in dysgranular S(I) and V(II). Thus, the non-competitive NMDA receptor antagonist suppressed activity from extrinsic neocortical sources, enhancing relative intracortical activity and stimulating limbic regions, while the competitive NMDA antagonist depressed metabolic activity in all cortical regions. These selective laminar and regional changes in metabolic activity may be due to an enhanced susceptibility of certain cortical circuits to non-competitive NMDA receptor antagonists.

UR - http://www.scopus.com/inward/record.url?scp=0025903517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025903517&partnerID=8YFLogxK

M3 - Article

C2 - 1828310

AN - SCOPUS:0025903517

VL - 7

SP - 260

EP - 268

JO - Synapse

JF - Synapse

SN - 0887-4476

IS - 4

ER -